Sign up to save your podcasts
Or
Share EMPA-REG: Good News for Kidneys, Too
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
EMPA-REG: Good News for Kidneys, Too
The positive effects of empagliflozin on renal disease are discussed by Dr Christoph Wanner, one of the lead authors of the EMPA-REG OUTCOME trial.
View all episodes
By MedscapeThe positive effects of empagliflozin on renal disease are discussed by Dr Christoph Wanner, one of the lead authors of the EMPA-REG OUTCOME trial.